Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127716491 | 12771649 | 1 | I | 20160909 | 20160922 | 20160922 | PER | US-AMGEN-USASP2016123962 | AMGEN | 0.00 | Y | 0.00000 | 20160922 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127716491 | 12771649 | 1 | PS | NEULASTA | PEGFILGRASTIM | 1 | Unknown | UNK UNK, UNK | U | 125031 | UNKNOWN FORMULATION | ||||||||
| 127716491 | 12771649 | 2 | SS | NEUPOGEN | FILGRASTIM | 1 | Unknown | UNK | U | 0 | UNKNOWN FORMULATION | ||||||||
| 127716491 | 12771649 | 3 | SS | CYTOXAN | CYCLOPHOSPHAMIDE | 1 | Unknown | UNK | 0 | ||||||||||
| 127716491 | 12771649 | 4 | SS | CYTOXAN | CYCLOPHOSPHAMIDE | 1 | 0 | ||||||||||||
| 127716491 | 12771649 | 5 | SS | CYTOXAN | CYCLOPHOSPHAMIDE | 1 | 0 | ||||||||||||
| 127716491 | 12771649 | 6 | SS | CYTOXAN | CYCLOPHOSPHAMIDE | 1 | 0 | ||||||||||||
| 127716491 | 12771649 | 7 | SS | CYTOXAN | CYCLOPHOSPHAMIDE | 1 | 0 | ||||||||||||
| 127716491 | 12771649 | 8 | SS | CYTOXAN | CYCLOPHOSPHAMIDE | 1 | 0 | ||||||||||||
| 127716491 | 12771649 | 9 | SS | CYTOXAN | CYCLOPHOSPHAMIDE | 1 | 0 | ||||||||||||
| 127716491 | 12771649 | 10 | SS | TAXOTERE | DOCETAXEL | 1 | Unknown | UNK | 0 | ||||||||||
| 127716491 | 12771649 | 11 | SS | TAXOTERE | DOCETAXEL | 1 | 0 | ||||||||||||
| 127716491 | 12771649 | 12 | SS | TAXOTERE | DOCETAXEL | 1 | 0 | ||||||||||||
| 127716491 | 12771649 | 13 | SS | TAXOTERE | DOCETAXEL | 1 | 0 | ||||||||||||
| 127716491 | 12771649 | 14 | SS | TAXOTERE | DOCETAXEL | 1 | 0 | ||||||||||||
| 127716491 | 12771649 | 15 | SS | TAXOTERE | DOCETAXEL | 1 | 0 | ||||||||||||
| 127716491 | 12771649 | 16 | SS | TAXOTERE | DOCETAXEL | 1 | 0 | ||||||||||||
| 127716491 | 12771649 | 17 | C | ARIMIDEX | ANASTROZOLE | 1 | UNK | 0 | |||||||||||
| 127716491 | 12771649 | 18 | C | ARIMIDEX | ANASTROZOLE | 1 | 0 | ||||||||||||
| 127716491 | 12771649 | 19 | C | ARIMIDEX | ANASTROZOLE | 1 | 0 | ||||||||||||
| 127716491 | 12771649 | 20 | C | ARIMIDEX | ANASTROZOLE | 1 | 0 | ||||||||||||
| 127716491 | 12771649 | 21 | C | ARIMIDEX | ANASTROZOLE | 1 | 0 | ||||||||||||
| 127716491 | 12771649 | 22 | C | ARIMIDEX | ANASTROZOLE | 1 | 0 | ||||||||||||
| 127716491 | 12771649 | 23 | C | ARIMIDEX | ANASTROZOLE | 1 | 0 | ||||||||||||
| 127716491 | 12771649 | 24 | C | AROMASIN | EXEMESTANE | 1 | UNK | 0 | |||||||||||
| 127716491 | 12771649 | 25 | C | AROMASIN | EXEMESTANE | 1 | 0 | ||||||||||||
| 127716491 | 12771649 | 26 | C | AROMASIN | EXEMESTANE | 1 | 0 | ||||||||||||
| 127716491 | 12771649 | 27 | C | AROMASIN | EXEMESTANE | 1 | 0 | ||||||||||||
| 127716491 | 12771649 | 28 | C | AROMASIN | EXEMESTANE | 1 | 0 | ||||||||||||
| 127716491 | 12771649 | 29 | C | AROMASIN | EXEMESTANE | 1 | 0 | ||||||||||||
| 127716491 | 12771649 | 30 | C | AROMASIN | EXEMESTANE | 1 | 0 | ||||||||||||
| 127716491 | 12771649 | 31 | C | FEMARA | LETROZOLE | 1 | UNK | 0 | |||||||||||
| 127716491 | 12771649 | 32 | C | FEMARA | LETROZOLE | 1 | 0 | ||||||||||||
| 127716491 | 12771649 | 33 | C | FEMARA | LETROZOLE | 1 | 0 | ||||||||||||
| 127716491 | 12771649 | 34 | C | FEMARA | LETROZOLE | 1 | 0 | ||||||||||||
| 127716491 | 12771649 | 35 | C | FEMARA | LETROZOLE | 1 | 0 | ||||||||||||
| 127716491 | 12771649 | 36 | C | FEMARA | LETROZOLE | 1 | 0 | ||||||||||||
| 127716491 | 12771649 | 37 | C | FEMARA | LETROZOLE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127716491 | 12771649 | 1 | Product used for unknown indication |
| 127716491 | 12771649 | 2 | Product used for unknown indication |
| 127716491 | 12771649 | 3 | Invasive ductal breast carcinoma |
| 127716491 | 12771649 | 4 | Invasive lobular breast carcinoma |
| 127716491 | 12771649 | 5 | Intraductal proliferative breast lesion |
| 127716491 | 12771649 | 6 | Invasive lobular breast carcinoma |
| 127716491 | 12771649 | 7 | Progesterone receptor assay positive |
| 127716491 | 12771649 | 8 | Oestrogen receptor assay positive |
| 127716491 | 12771649 | 9 | Human epidermal growth factor receptor negative |
| 127716491 | 12771649 | 10 | Invasive ductal breast carcinoma |
| 127716491 | 12771649 | 11 | Invasive lobular breast carcinoma |
| 127716491 | 12771649 | 12 | Intraductal proliferative breast lesion |
| 127716491 | 12771649 | 13 | Invasive lobular breast carcinoma |
| 127716491 | 12771649 | 14 | Progesterone receptor assay positive |
| 127716491 | 12771649 | 15 | Oestrogen receptor assay positive |
| 127716491 | 12771649 | 16 | Human epidermal growth factor receptor negative |
| 127716491 | 12771649 | 17 | Invasive ductal breast carcinoma |
| 127716491 | 12771649 | 18 | Invasive lobular breast carcinoma |
| 127716491 | 12771649 | 19 | Intraductal proliferative breast lesion |
| 127716491 | 12771649 | 20 | Invasive lobular breast carcinoma |
| 127716491 | 12771649 | 21 | Progesterone receptor assay positive |
| 127716491 | 12771649 | 22 | Oestrogen receptor assay positive |
| 127716491 | 12771649 | 23 | Human epidermal growth factor receptor negative |
| 127716491 | 12771649 | 24 | Invasive ductal breast carcinoma |
| 127716491 | 12771649 | 25 | Invasive lobular breast carcinoma |
| 127716491 | 12771649 | 26 | Intraductal proliferative breast lesion |
| 127716491 | 12771649 | 27 | Invasive lobular breast carcinoma |
| 127716491 | 12771649 | 28 | Progesterone receptor assay positive |
| 127716491 | 12771649 | 29 | Oestrogen receptor assay positive |
| 127716491 | 12771649 | 30 | Human epidermal growth factor receptor negative |
| 127716491 | 12771649 | 31 | Invasive ductal breast carcinoma |
| 127716491 | 12771649 | 32 | Invasive lobular breast carcinoma |
| 127716491 | 12771649 | 33 | Intraductal proliferative breast lesion |
| 127716491 | 12771649 | 34 | Invasive lobular breast carcinoma |
| 127716491 | 12771649 | 35 | Progesterone receptor assay positive |
| 127716491 | 12771649 | 36 | Oestrogen receptor assay positive |
| 127716491 | 12771649 | 37 | Human epidermal growth factor receptor negative |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127716491 | 12771649 | Arthralgia | |
| 127716491 | 12771649 | Coccydynia | |
| 127716491 | 12771649 | Gait disturbance | |
| 127716491 | 12771649 | Pain in extremity | |
| 127716491 | 12771649 | Pelvic pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127716491 | 12771649 | 3 | 20100503 | 0 | ||
| 127716491 | 12771649 | 10 | 20100503 | 0 | ||
| 127716491 | 12771649 | 17 | 20100901 | 0 | ||
| 127716491 | 12771649 | 24 | 20100901 | 0 | ||
| 127716491 | 12771649 | 31 | 20100901 | 0 |